{"id":43932,"date":"2022-05-16T14:01:06","date_gmt":"2022-05-16T12:01:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/"},"modified":"2022-05-16T14:01:06","modified_gmt":"2022-05-16T12:01:06","slug":"perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/","title":{"rendered":"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing"},"content":{"rendered":"
\n

\nLatest addition to Company\u2019s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients<\/i>\n<\/p>\n

WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc.<\/a>, a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing<\/a> (urWGS) through PerkinElmer Genomics<\/a>. This addition to the Company\u2019s portfolio of whole genome sequencing (WGS) offerings provides physicians with comprehensive, meaningful results in five days to help inform clinical management and improve outcomes for critically ill patients in neonatal and pediatric intensive care units (NICUs and PICUs). With many genetic diseases being chronic and progressive in nature, reducing the time to reaching an accurate diagnosis can eliminate unnecessary procedures, initiate treatment and improve clinical outcomes.\n<\/p>\n

\nThe PerkinElmer Genomics urWGS offering uses a dried blood spot sample to provide phenotype-driven analysis with a mean coverage of 40x of a patient\u2019s genome. Studies suggest that up to 15 percent<\/a> of disease-causing genetic variants may be found in the non-coding regions of the genome, which WGS helps identify. In addition to an analysis of the mitochondrial genome, CNV detection \u2013 which identifies deletions, duplications, and other gene- and chromosomal-level events, SMA and a repeat disorders screen \u2013 the PerkinElmer urWGS offering includes a StepOne\u00ae Comprehensive Biochemical Profile<\/a>. The StepOne offering screens for more than 70 inherited conditions and disorders, including the Recommended Universal Newborn Screening Panel (RUSP) and many others that may not be found in state-mandated programs.\n<\/p>\n

\n\u201cIncreasingly, whole genome sequencing is proving its value as a first-tier clinical test for many patients, especially in a NICU and PICU where timely clinical decisions are critical for timely intervention,\u201d said Madhuri Hegde, PhD, FACMG, SVP and chief scientific officer, Global Lab Services, PerkinElmer Inc. \u201cBy making services such as this urWGS combined with StepOne available to more hospital systems and physicians, our hope is that we may help shorten the diagnostic odyssey for more newborns and their families. With PerkinElmer\u2019s global leadership in newborn screening using dried blood spot card technology, we will continue to enhance urWGS with additional assays.\u201d\n<\/p>\n

\nAs a result of informing and initiating changes in clinical management, rapid WGS tests have been shown to reduce healthcare costs<\/a> for patients in NICUs and PICUs. Additional benefits of these testing services include the elimination of unnecessary tests and procedures, and reduced length of hospital stays.\n<\/p>\n

\nPerkinElmer Genomics is among the first commercial clinical laboratories to receive approval from the State of New York for its next generation sequencing-based method for WGS using saliva, whole blood, and dried blood spot specimens. In December 2021, the Company also launched a prenatal WGS test<\/a> offering, further expanding its capabilities as a leader in this space.\n<\/p>\n

\nThe PerkinElmer Genomics urWGS test is offered as a proband-only or TRIO test. For more information on both tests, ordering instructions and a summary of all PerkinElmer Genomics WGS offerings, visit the webpage here.<\/a>\n<\/p>\n

\nAbout PerkinElmer<\/b>\n<\/p>\n

\nPerkinElmer is a leading, global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalized drugs, monitor the safety and quality of our food, and drive environmental and applied analysis excellence. With an 85-year legacy of advancing science and a mission of innovating for a healthier world, our dedicated team of more than 16,000 collaborates closely with commercial, government, academic and healthcare customers to deliver reagents, assays, instruments, automation, informatics and strategic services that accelerate workflows, deliver actionable insights and support improved decision making. We are also deeply committed to good corporate citizenship through our dynamic ESG and sustainability programs. The Company reported revenues of approximately $5 billion in 2021, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available at www.perkinelmer.com<\/a>. Follow PerkinElmer on LinkedIn<\/a>, Twitter<\/a>, Facebook<\/a>, Instagram<\/a>, and YouTube<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Relations:<\/b>
Chet Murray
\n
(781) 663-5719
\n
chet.murray@perkinelmer.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Latest addition to Company\u2019s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics. This addition to the Company\u2019s … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-43932","6":"format-standard","7":"category-industry"},"yoast_head":"\nPerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Latest addition to Company\u2019s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics. This addition to the Company\u2019s ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-16T12:01:06+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing\",\"datePublished\":\"2022-05-16T12:01:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\\\/\"},\"wordCount\":651,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\\\/\",\"name\":\"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-05-16T12:01:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/","og_locale":"en_US","og_type":"article","og_title":"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing - Pharma Trend","og_description":"Latest addition to Company\u2019s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics. This addition to the Company\u2019s ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-16T12:01:06+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing","datePublished":"2022-05-16T12:01:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/"},"wordCount":651,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/","url":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/","name":"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-05-16T12:01:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/perkinelmer-expands-genomic-testing-services-with-ultrarapid-whole-genome-sequencing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/43932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=43932"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/43932\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=43932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=43932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=43932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}